Overview
- Ultrahuman secured INR 100 crore from Alteria Capital to support entry into Canada, Mexico and Australia and to scale software-led features and partnerships.
- US International Trade Commission cease-and-desist orders that took effect in October bar import and sale of Ultrahuman’s current Ring AIR model in the United States.
- Ultrahuman says the ITC action does not affect its sleep monitor, CGM and blood testing lines, and it expects existing US ring inventory to prevent an FY26 revenue hit.
- The startup is redesigning its smart ring for the US market and is waiting for FCC approvals while seeking clarity on whether devices made at its Texas facility could be exempt from the import ban.
- FY25 operating revenue reached INR 564.7 crore with nearly 60% from the US and net profit of INR 71.5 crore, and the Delhi High Court’s Division Bench has reinstated the company’s India suit related to the Oura dispute.